The present study sought to investigate whether a single night of partial sleep deprivation (PSD) would alter fasting insulin sensitivity and cephalic phase insulin release (CPIR) in humans. A rise in circulating insulin in response to food-related sensory stimulation may prepare tissues to break down ingested glucose, e.g. by stimulating rate-limiting glycolytic enzymes. In addition, given insulin's anorexigenic properties once it reaches the brain, the CPIR may serve as an early peripheral satiety signal. Against this background, in the present study 16 men participated in two separate sessions: one night of PSD (4.25 h sleep) versus one night of full sleep (8.5 h sleep). In the morning following each sleep condition, subjects' oral cavities were rinsed with a 1-molar sucrose solution for 45 s, preceded and followed by blood sampling for repeated determination of plasma glucose and serum insulin concentrations (À3, +3, +5, +7, +10 and +20 min). Our main result was that PSD, compared with full sleep, was associated with significantly higher peripheral insulin resistance, as indicated by a higher fasting homeostasis model assessment of insulin resistance index (+16%, P = 0.025). In contrast, no CPIR was observed in any of the two sleep conditions. Our findings indicate that a single night of PSD is already sufficient to impair fasting insulin sensitivity in healthy men. In contrast, brief oral cavity rinsing with sucrose solution did not change serum insulin concentrations, suggesting that a blunted CPIR is an unlikely mechanism through which acute sleep loss causes metabolic perturbations during morning hours in humans.
The present study sought to investigate whether a single night of partial sleep deprivation (PSD) would alter fasting insulin sensitivity and cephalic phase insulin release (CPIR) in humans. A rise in circulating insulin in response to food-related sensory stimulation may prepare tissues to break down ingested glucose, e.g. by stimulating rate-limiting glycolytic enzymes. In addition, given insulin's anorexigenic properties once it reaches the brain, the CPIR may serve as an early peripheral satiety signal. Against this background, in the present study 16 men participated in two separate sessions: one night of PSD (4.25 h sleep) versus one night of full sleep (8.5 h sleep). In the morning following each sleep condition, subjects' oral cavities were rinsed with a 1-molar sucrose solution for 45 s, preceded and followed by blood sampling for repeated determination of plasma glucose and serum insulin concentrations (À3, +3, +5, +7, +10 and +20 min). Our main result was that PSD, compared with full sleep, was associated with significantly higher peripheral insulin resistance, as indicated by a higher fasting homeostasis model assessment of insulin resistance index (+16%, P = 0.025). In contrast, no CPIR was observed in any of the two sleep conditions. Our findings indicate that a single night of PSD is already sufficient to impair fasting insulin sensitivity in healthy men. In contrast, brief oral cavity rinsing with sucrose solution did not change serum insulin concentrations, suggesting that a blunted CPIR is an unlikely mechanism through which acute sleep loss causes metabolic perturbations during morning hours in humans.
IN TROD UCTI ON
In humans, partial sleep deprivation (PSD) for a duration lasting from 1 day to 1 week has been linked to impaired postprandial glucose disposal (Buxton et al., 2010; Donga et al., 2010; Schmid et al., 2011; Spiegel et al., 1999 ; also reviewed in Cedernaes et al., 2015a) , possibly as a result of insulin resistance (Broussard et al., 2012 (Broussard et al., , 2015 and tissuespecific clock disruption (Cedernaes et al., 2015b ). In contrast, evidence for the effects of PSD on fasting circulating concentrations of insulin and glucose are less conclusive. For instance, a recent study involving 21 male adolescents revealed that three consecutive nights of PSD (4 h night À1 ) increased fasting insulin resistance-as assessed by the fasting homeostasis model assessment of insulin resistance (HOMA-IR) index (Matthews et al., 1985) -by approximately 59%, compared with values obtained after three nights of unrestricted sleep (Klingenberg et al., 2013) . Studies exploring the metabolic effects of one night of PSD in adults did not, however, reveal such fasting insulin resistance-promoting effects of PSD (e.g. Donga et al., 2010) . These controversial findings thus warrant further investigation into the acute effects of PSD on fasting insulin resistance in humans.
Another aspect of human insulin metabolism that has not been investigated thoroughly in relation to PSD is the cephalic phase insulin release (CPIR). A recent study in humans has demonstrated that the CPIR can occur after 45 s of uninterrupted stimulation of the oral cavity with 1-molar sucrose solution (Just et al., 2008) . The CPIR is initiated through sensory stimulation, involving oral taste receptors. This sensory input triggers a rapid but small increase in blood plasma insulin via parasympathetic vagal efferences (Berthoud and Jeanrenaud, 1982; Berthoud et al., 1981) . The CPIR has been proposed to prepare tissues to break down ingested glucose (Zafra et al., 2006) , e.g. by stimulating rate-limiting glycolytic enzymes. Given that insulin acts as an important satiety signal once it reaches the brain (Benedict et al., 2008) , it could also be speculated that the rise in circulating insulin in response to food-related sensory stimulation may serve as an early peripheral satiety signal.
Importantly, sleep restriction and sleep misalignment studies have found consistently that insulin secretionindicative of beta cell function-is impaired following these various types of sleep loss (Buxton et al., 2010 (Buxton et al., , 2012 Morris et al., 2015; Spiegel et al., 1999) . As the CPIR depends upon adequate insulin release without beta cells actually responding to higher glucose levels, this test might be used as a test for evaluating whether sleep loss-induced beta cells dysfunction is dependent upon neuronal dysfunctioning (i.e. impaired autonomic signalling) or at the humoral level (i.e. via impaired glucose-stimulated insulin secretion).
Against this background, in the present study involving 16 metabolically healthy young men we had two main objectives: first, we sought to investigate whether a single night of PSD would be associated with a higher HOMA-IR index during breakfast hours. Secondly, we aimed to examine how PSD would alter the CPIR when rinsing the oral cavity with a sucrose solution.
METHODS

Participants
Sixteen men participated in the study [aged 22.88 AE 0.66 years; body mass index (BMI) 22.88 AE 0.45 kg m 2 ]. They were non-smokers and had regular sleep habits (Pittsburgh Sleep Quality Index score ≤5 (Buysse et al., 1989) ; habitual sleep of 7-9 h night À1 ). An anamnestic interview prior to experiments ensured that participants did not suffer from metabolic, neurological, psychiatric diseases or sleep disorders, and that none of them were on medication or using dietary supplements. Additionally, all participants underwent a 2-h oral glucose tolerance test (OGTT) during screening to ensure that they did not have impaired glycaemic control (i.e. their 2-h post-OGTT plasma glucose value was below 7.8 mM L À1 ). Note that subjects included in the present study reported having a regular breakfast during morning hours (i.e.~07:00-09:00 hours). A prestudy diary that was kept for 1 week by the participants was used to confirm normal sleep timing and sleep duration. Participants' ability to sleep efficiently in our sleep laboratory was tested further in a separate adaptation night using sleep polysomnography, which also served to habituate subjects to our experimental setting. Adaptation nights were conducted within the week before the subject's first experimental session. Subjects were considered eligible for inclusion into the present study only if sleep parameters during their adaption night in the sleep laboratory were within the standard range (e.g. sleep onset latency less than 30 min). All participants gave written informed consent. The study was conducted in accordance with the Helsinki Declaration and was approved by the Regional Ethical Review Board in Uppsala (EPN 2014/242/1).
EXPERIMENTAL PROCEDURE
The study utilized a within-subject repeated-measures design, during which participants took part in two separate experimental conditions, sleep and PSD, in a counterbalanced order. During each sleep condition, participants stayed in our sleep laboratories at the Biomedical Research Centre at Uppsala University, Sweden. Upon arrival at 17:30 hours on the baseline day, participants were provided a standardized dinner, and were then prepared for sleep polysomnography. In the sleep condition, lights were off between 22:30 and 07:00 hours. During this time, Embla A10 recorders (Flaga hf, Reykjavik, Iceland) were used to monitor sleep [with electroencephalography (EEG), electro-oculography (EOG) and electromyography (EMG)]. In the PSD condition, sleep was allowed between 02:45 and 07:00 hours, with lights kept at 6 lux at eye-level between 22:30 and 02:45 hours, during which participants' wakefulness was ensured by continuous monitoring by the experimenters. Standard criteria were used to assess sleep stages (Rechtschaffen and Kales, 1968) . Following each sleep duration condition, subjects sipped and spit a sucrose solution at around 08:30 hours (detailed procedure description below), preceded and followed by blood sampling via an intravenous dwelling cannula for the determination of plasma glucose and serum insulin concentrations (À3, +3, +5, +7, +10 and +20 min, reference time-point 08:30 hours). Plasma glucose and serum insulin concentrations were analysed at the central laboratory of Uppsala University Hospital.
CPIR test
The CPIR procedure was adopted from Just et al. (2008) . The sucrose solution was prepared by dissolving sucrose (1.0 M) in water. Following collection of the baseline blood sample (i.e. at À 3 min; referenced to tasting the solution), participants were requested to quickly (within 2 s) sip 10 mL of the sucrose solution. They then swished the liquid in their closed mouths for 45 s before spitting it out. Immediately afterwards, subjects rated the taste intensity of the sucrose solution on a 100-mm visual analogue scale (VAS).
Statistical analysis
Repeated-measures analysis of variance (ANOVA; withinsubject factors: sleep duration condition, time) was performed using SPSS version 21 (SPSS Inc., Chicago, IL, USA). Dependent variables were serum insulin, plasma glucose, HOMA-IR [for a description of the calculation, please see Matthews et al. (1985) ], sleep stages and taste intensity rating. The Greenhouse-Geisser method was used to correct for sphericity deviations. Two-tailed P-values below 0.05 were considered significant. Data are presented as means AE standard error of the mean (SEM).
RESUL TS Sleep characteristics
During the 4.25-h sleep condition, subjects slept on average 240 min less than in the 8.5-h sleep condition (P < 0.001 for the sleep condition main effect; Table 1 ). Compared with a full night's sleep, sleeping just half a night reduced proportions of time spent in sleep stages N2 and rapid eye movement (REM) sleep, whereas the proportion of sleep stage N3 (also known as slow wave sleep, SWS) was increased (Table 1) .
Serum insulin, plasma glucose and HOMA-IR following short and full sleep Short sleep (i.e. PSD), compared with full sleep, was followed by significantly higher serum insulin concentrations the next morning (7.16 AE 0.78 versus 6.22 AE 0.78 lIU mL À1 , F (1.0) = 7.19, P = 0.017; Fig. 1 ), whereas plasma glucose concentrations did not differ between sleep conditions (5.44 AE 0.12 versus 5.34 AE 0.12 mM L À1 , F (1.0) = 1.63, P = 0.22; Fig. 1 ). Additional analyses revealed that the HOMA-IR index was 16% higher following PSD than after a full night of sleep (1.77 AE 0.23 versus 1.52 AE 0.23 mM L À1 9 lIU L À1 9 22.5
À1
, F (1.0) = 6.23, P = 0.025; Fig. 1 ). A linear regression analysis utilizing individual differences between conditions (i.e. PSD minus sleep), however, revealed no associations between the HOMA-IR index (averaged across all time-points) and sleep stages (N2: b = 0.242, P = 0.512; N3: b = À0.178, P = 0.628; and REM sleep: b = À0.170, P = 0.535).
Concerning the cephalic phase insulin response (CPIR), repeated-measures ANOVA revealed neither a significant main effect for time (F (1.75) = 0.20, P = 0.79) nor a significant interaction between the within-subject factors sleep condition and time (F (2.48) = 0.29, P = 0.79). Similar null findings for the CPIR were obtained when referencing post-taste test serum insulin concentrations to baseline serum insulin concentration (data not shown). Finally, subjective taste intensity of the sucrose solution did not differ between the sleep conditions (50.6 AE 6.1 versus 53.9 AE 6.0 mm, F (1.0) = 0.48, P = 0.50).
DISCUSSION
By utilizing a randomized within-subject design in which metabolically healthy young men were participating in a counterbalanced order in both a full sleep and a partial sleep deprivation (PSD) condition, we demonstrate that a single night of PSD is sufficient to reduce fasting insulin sensitivity by approximately~16%. The public health relevance of this finding is underscored by results from the International Bedroom Poll 2013. In this survey, more than half of adults aged between 20 and 55 years reported insufficient sleep on one or several weekdays. Moreover, our results suggest that assessing patients' sleep (e.g. by questionnaires) might be a seemingly feasible clinical tool to identify people at risk for insulin resistance. Finally, based on our findings it might be that intra-individual differences in sleep duration before regular routine health checkups may explain intra-individual variances in fasting circulating concentrations of insulin in patients.
The question that remains is how a single night of PSD leads to fasting insulin resistance in young men. Previous studies have linked sleep stages dissimilarly to peripheral daytime insulin resistance in young men. For instance, a study involving 16 young men demonstrated that a single night with suppression of SWS reduced postprandial insulin sensitivity up to 20%, whereas disturbed REM sleep did not affect this measure (Herzog et al., 2013) . However, in our study no such associations were found between sleep stages and fasting insulin resistance. A recent study offers an alternative explanation as to why PSD may increase fasting insulin resistance. In this study involving seven healthy adults, it has been demonstrated that four consecutive days of PSD (4.5 h night À1 ) reduced the ability of insulin to stimulate intracellular downstream pathways in subcutaneous adipose tissue by approximately 30% (Broussard et al., 2012) . In another study involving 19 young non-diabetic men, PSD for 4 consecutive nights (4.5 h in bed night
À1
) resulted in increased circulating concentrations of free fatty acids (FFAs) (Broussard et al., 2015) , which are known to impair insulin-stimulated muscle uptake of glucose in humans (Roden et al., 1996) . To what extent such biochemical alterations may have contributed to Data are shown as mean AE standard error of the mean. TST = total sleep time; WASO = wake after sleep onset; N1 = sleep stage 1; N2 = sleep stage 2; N3 = slow wave sleep; REM = rapid eye movement sleep. P-values, degrees of freedom (df) and F-values derived from repeated-measures analysis of variance (ANOVA) (within-subject factor: sleep duration). insulin resistance after PSD, however, cannot be extrapolated from our study, and as such warrants further investigation. As studies have shown that sleep that is not properly aligned can reduce insulin sensitivity (Buxton et al., 2012) , the timing of the participants' sleep may have played a role in the findings observed herein. Awakening results in a subsequent sharp rise in cortisol levels [the cortisol awakening response (Clow et al., 2010) ] in a light-dependent manner (Leproult et al., 2001) . Cortisol has been shown to affect, e.g. peripheral oscillators and peripheral glucose metabolism (So et al., 2009) . However, our participants were woken at the same time-point in both sleep conditions (i.e. 07:00 hours), thereby minimizing a potential confound of different awakening time-points on our dependent variables (i.e. HOMA-IR and CPIR).
The second objective of our study was to investigate whether PSD would alter the cephalic phase insulin response (CPIR). To this aim, following both PSD and a full night of sleep, subjects were rinsing the oral cavity with a sucrose solution. A recent study utilizing a similar experimental design (except for sleep versus PSD) found that the CPIR can occur after 45 s of uninterrupted stimulation of the oral cavity with sucrose (Just et al., 2008) . However, contrary to this previous finding, no CPIR was observed in the morning following any of our two sleep conditions. These opposing results may be explained by various factors. For instance, in the study by Just et al. (2008) , CPIR measurements started at 06:00 hours, whereas ours started 2.5 h later, in both studies following a 12-h-long fast. In addition to a circadian rhythm of circulating cortisol levels, studies have shown, for instance, that serum cortisol concentrations typically rise upon food intake (Benedict et al., 2005) . However, this effect is seen primarily during noon and evening times, whereas no such meal-related cortisol peak occurs during morning hours (Follenius et al., 1982) . Given that we tested the CPIR only at 08:30 hours, it cannot be ruled out that possible effects of PSD on CPIR may have been observed at other time-points. Another tentative explanation for these discrepant results between our study and the study by Just et al. (2008) could be that our participants were possibly generally less aroused by sweet taste stimulation than those of the other study. Finally, in the study by Just et al. (2008) , subjects were informed about the aims of the study (i.e. they were not blinded to the study hypothesis), whereas our study participants remained blinded to the study aim.
One study found that oral exposure to an apple pie elicited a CPIR, whereas sucrose, saccharin and aspartame dissolved in water did not (Teff et al., 1995) . This suggests that the food texture rather than taste sensation (i.e. liquid versus solid food), may play an important role in stimulating a CPIR in humans, and as such may explain further why we did not observe a CPIR in any of the two sleep conditions. Another shortcoming of the 'sip and spit' procedure utilized in our study to induce a CPIR is that pharyngeal and oesophageal cavities are not stimulated chemically and physically. The stimulation of these compartments has been suggested to be important for generating various endocrinological aspects of the cephalic phase response, including for insulin (Brand et al., 1982) .
CONCLUSI ON
Our results suggest that sleeping at least 7 h per night-as has recently been recommended to adults by the US National Sleep Foundation-may help to reduce the risk for insulin resistance in humans. Moreover, they indicate that an altered CPIR (and thereby likely also disrupted autonomic signaling which regulates the CPIR) is an unlikely mechanism through which at least one night of PSD causes metabolic dysfunctions. Importantly, when interpreting our study results, the reader must, however, take into account that various factors may determine the extent to which PSD impair fasting insulin metabolism and CPIR (Cedernaes et al., 2015a,b) . As such, our findings warrant further investigation in, for example, females, elderly subjects or diseased (obese) individuals.
